Cargando…

Fibroblast Growth Factor—14 Acts as Tumor Suppressor in Lung Adenocarcinomas

Investigation of the molecular dynamics in lung cancer is crucial for the development of new treatment strategies. Fibroblast growth factor (FGF) 14 belongs to the FGF family, which might play a crucial role in cancer progression. We analyzed lung adenocarcinoma (LUAC) patients samples and found tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Turkowski, Kati, Herzberg, Frederik, Günther, Stefan, Brunn, David, Weigert, Andreas, Meister, Michael, Muley, Thomas, Kriegsmann, Mark, Schneider, Marc A., Winter, Hauke, Thomas, Michael, Grimminger, Friedrich, Seeger, Werner, Savai Pullamsetti, Soni, Savai, Rajkumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466013/ https://www.ncbi.nlm.nih.gov/pubmed/32707902 http://dx.doi.org/10.3390/cells9081755

Ejemplares similares

Interferon Regulatory Factor 9 Promotes Lung Cancer Progression via Regulation of Versican
por: Brunn, David, et al.
Publicado: (2021)

Picturing of the Lung Tumor Cellular Composition by Multispectral Flow Cytometry
por: Olesch, Catherine, et al.
Publicado: (2022)

Fibrocytes boost tumor-supportive phenotypic switches in the lung cancer niche via the endothelin system
por: Weigert, Andreas, et al.
Publicado: (2022)

Hidden Treasures: Macrophage Long Non-Coding RNAs in Lung Cancer Progression
por: Karger, Annika, et al.
Publicado: (2021)

Epigenetic Inactivation of the Tumor Suppressor IRX1 Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired Prognosis
por: Küster, Miriam M., et al.
Publicado: (2020)

Exposomes to Exosomes: Exosomes as Tools to Study Epigenetic Adaptive Mechanisms in High-Altitude Humans
por: Padmasekar, Manju, et al.
Publicado: (2021)

Reply to Zheng et al.
por: Eul, Bastian, et al.
Publicado: (2021)

Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma
por: Banat, G-Andre, et al.
Publicado: (2015)

Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy
por: Zheng, Xiang, et al.
Publicado: (2017)

Reprogramming of tumor-associated macrophages by targeting β-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancer
por: Sarode, Poonam, et al.
Publicado: (2020)

A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
por: Dabral, Swati, et al.
Publicado: (2019)

Metabolism in tumour-associated macrophages: a quid pro quo with the tumour microenvironment
por: Zheng, Xiang, et al.
Publicado: (2020)

Zooming into Cellular and Molecular Heterogeneity of Pulmonary Hypertension. What More Single-Cell Omics Can Offer
por: Chelladurai, Prakash, et al.
Publicado: (2021)

New Insights into the Epigenomic Landscape of Small-Cell Lung Cancer: A Game Changer?
por: Sarode, Poonam, et al.
Publicado: (2022)

Cancer and pulmonary hypertension: Learning lessons and real-life interplay
por: Pullamsetti, Soni Savai, et al.
Publicado: (2020)

Epigenetic Mechanisms in Parenchymal Lung Diseases: Bystanders or Therapeutic Targets?
por: Avci, Edibe, et al.
Publicado: (2022)

ADPGK‐AS1 long noncoding RNA switches macrophage metabolic and phenotypic state to promote lung cancer growth
por: Karger, Annika, et al.
Publicado: (2023)

Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives
por: Chelladurai, Prakash, et al.
Publicado: (2016)

A FOX-like Mechanism Regulating Lung Fibroblasts: Are We Getting There?
por: Pullamsetti, Soni Savai, et al.
Publicado: (2020)

Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk
por: Sarode, Poonam, et al.
Publicado: (2020)

Long Noncoding RNAs: Emerging Regulators of Platelet-derived Growth Factor Signaling
por: Valasarajan, Chanil, et al.
Publicado: (2022)

The Multi-Modal Effect of the Anti-fibrotic Drug Pirfenidone on NSCLC
por: Marwitz, Sebastian, et al.
Publicado: (2020)

Characterization of a murine model of monocrotaline pyrrole-induced acute lung injury
por: Dumitrascu, Rio, et al.
Publicado: (2008)

Hypoxic pulmonary hypertension in mice with constitutively active platelet-derived growth factor receptor-β
por: Dahal, Bhola K., et al.
Publicado: (2011)

Phosphodiesterase 10A Upregulation Contributes to Pulmonary Vascular Remodeling
por: Tian, Xia, et al.
Publicado: (2011)

Epigenetic silencing of downstream genes mediated by tandem orientation in lung cancer
por: Kiehl, Steffen, et al.
Publicado: (2017)

Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis
por: Nikolova, Sevdalina, et al.
Publicado: (2010)

Correction to: Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis
por: Nikolova, Sevdalina, et al.
Publicado: (2022)

Glycogen Synthase Kinase 3beta Contributes to Proliferation of Arterial Smooth Muscle Cells in Pulmonary Hypertension
por: Sklepkiewicz, Piotr, et al.
Publicado: (2011)

FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis
por: Al‐Tamari, Hamza M, et al.
Publicado: (2017)

Utility and Drawbacks of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Lung Cancer
por: Kandra, Prameela, et al.
Publicado: (2022)

Correction to: Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
por: Udalov, Sergey, et al.
Publicado: (2022)

EpiHope for the Treatment of Pulmonary Arterial Hypertension: Selective versus Nonselective BET Inhibition
por: Pullamsetti, Soni Savai, et al.
Publicado: (2019)

In-Silico Design of a Novel Tridecapeptide Targeting Spike Protein of SARS-CoV-2 Variants of Concern
por: Rajpoot, Sajjan, et al.
Publicado: (2021)

Effects of anti-inflammatory vagus nerve stimulation on the cerebral microcirculation in endotoxinemic rats
por: Mihaylova, Stanka, et al.
Publicado: (2012)

Inactivation of nuclear histone deacetylases by EP300 disrupts the MiCEE complex in idiopathic pulmonary fibrosis
por: Rubio, Karla, et al.
Publicado: (2019)

Interactions between neutrophils and non-small cell lung cancer cells: enhancement of tumor proliferation and inflammatory mediator synthesis
por: Hattar, Katja, et al.
Publicado: (2014)

Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension
por: Weiss, Astrid, et al.
Publicado: (2019)

Case Report: Durable therapy response to Osimertinib in rare EGFR Exon 18 mutated NSCLC
por: Cekay, Michael, et al.
Publicado: (2023)

Histological and molecular plasticity of ALK-positive non-small-cell lung cancer under targeted therapy: a case report
por: Ball, Markus, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c4le0pace1bu1tga0unssjckt3